Avidity Partners Management LP Revolution Medicines, Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 446,200 shares of RVMD stock, worth $17.2 Million. This represents 2.21% of its overall portfolio holdings.
Number of Shares
446,200
Previous 790,000
43.52%
Holding current value
$17.2 Million
Previous $35.8 Million
45.48%
% of portfolio
2.21%
Previous 2.2%
Shares
11 transactions
Others Institutions Holding RVMD
# of Institutions
298Shares Held
168MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$657 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$516 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$509 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$365 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$305 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.37B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...